高血压、糖尿病、动脉粥样硬化与非酒精性脂肪性肝炎:因果还是后果?
综述批判性讨论非酒精性脂肪性肝病(NAFLD)与代谢综合征组分(尤其2型糖尿病、高血压)之间存在双向关系的大量临床证据,并指出NAFLD的存在与严重程度与2型糖尿病和高血压发病风险升高相关,长期前瞻性研究显示NAFLD独立预测致死性和非致死性心血管事件,同时汇总NAFLD可能促进高血压、2型糖尿病和心血管疾病发生的生物学机制。
要点
- NAFLD与代谢综合征组分尤其是2型糖尿病和高血压之间存在双向关系。
- NAFLD的存在与严重程度与2型糖尿病和高血压发病风险升高相关。
- 长期前瞻性研究显示NAFLD独立预测致死性和非致死性心血管事件。
核心结论
- 大量临床证据提示NAFLD可能先于和/或促进2型糖尿病、高血压及动脉粥样硬化/心血管疾病的发生,且NAFLD与代谢综合征组分尤其2型糖尿病和高血压之间存在双向关系。
研究设计与样本
- 综述,批判性讨论支持NAFLD与代谢综合征各组分尤其2型糖尿病和高血压之间存在双向关系的不断扩展的临床证据,并汇总NAFLD与心血管疾病发病率和死亡率强关联的现有认识及最新推测的生物学机制。
主要发现
- NAFLD传统上被认为是代谢综合征的后果,但其与代谢综合征组分尤其2型糖尿病、高血压和心血管疾病的联系比先前认为的更复杂。
- NAFLD的不良影响远超肝脏,大量临床证据提示NAFLD可能先于和/或促进2型糖尿病、高血压和动脉粥样硬化/心血管疾病的发生。
- 发生这些心血管代谢疾病的风险与NAFLD的基础严重程度平行。
- 不断积累的证据提示NAFLD的存在与严重程度与2型糖尿病和高血压发病风险升高相关。
- 长期前瞻性研究提示NAFLD的存在与严重程度独立预测致死性和非致死性心血管事件。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Non-alcoholic fatty liver disease (NAFLD) has become one of the most common forms of chronic liver disease worldwide and its prevalence is expected to continue rising. NAFLD has traditionally been considered a consequence of metabolic syndrome (MetS). However, the link between NAFLD and MetS components, especially type 2 diabetes mellitus (T2DM), hypertension (HTN), and cardiovascular disease (CVD) is more complex than previously thought. Indeed, the adverse effects of NAFLD extend far beyond the liver, with a large body of clinical evidence now suggesting that NAFLD may precede and/or promote the development of T2DM, HTN and atherosclerosis/CVD. The risk of developing these cardiometabolic diseases parallels the underlying severity of NAFLD. Accumulating evidence suggests that the presence and severity of NAFLD is associated with an increased risk of incident T2DM and HTN. Moreover, long-term prospective studies indicate that the presence and severity of NAFLD independently predicts fatal and nonfatal CVD events. In this review, we critically discuss the rapidly expanding body of clinical evidence that supports the existence of a bi-directional relationship between NAFLD and various components of MetS, particularly T2DM and HTN, as well as the current knowledge regarding a strong association between NAFLD and CVD morbidity and mortality. Finally, we discuss the most updated putative biological mechanisms through which NAFLD may contribute to the development of HTN, T2DM and CVD.
引用
- Lonardo A, Nascimbeni F, Mantovani A, et al. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? J Hepatol. 2017. PMID: 29122390. doi:10.1016/j.jhep.2017.09.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。